1-1 of 1
Jonathan Rothberg
Close
Sort by
Journal Articles

LAM-003, a new drug for treatment of tyrosine kinase inhibitor–resistant FLT3-ITD–positive AML

Neil Beeharry, Sean Landrette, Sophia Gayle, Marylens Hernandez, Jeff E. Grotzke, Peter R. Young, Paul Beckett, Xuan Zhang, Bing Z. Carter, Michael Andreeff, Stephanie Halene, Tian Xu, Jonathan Rothberg, Henri Lichenstein
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3661–3673.
https://doi.org/10.1182/bloodadvances.2019001068
Published: 2019
Includes: Supplemental data